TY - JOUR T1 - Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry JF - RMD Open JO - RMD Open DO - 10.1136/rmdopen-2020-001505 VL - 7 IS - 1 SP - e001505 AU - Bente Glintborg AU - Dorte Vendelbo Jensen AU - Sara Engel AU - Lene Terslev AU - Mogens Pfeiffer Jensen AU - Oliver Hendricks AU - Mikkel Østergaard AU - Simon Horskjær Rasmussen AU - Thomas Adelsten AU - Ada Colic AU - Kamilla Danebod AU - Malene Kildemand AU - Anne Gitte Loft AU - Heidi Lausten Munk AU - Jens Kristian Pedersen AU - René Drage Østgård AU - Christian Møller Sørensen AU - Niels Steen Krogh AU - Jette Agerbo AU - Connie Ziegler AU - Merete Lund Hetland Y1 - 2021/01/01 UR - http://rmdopen.bmj.com/content/7/1/e001505.abstract N2 - Aims In Danish patients with inflammatory rheumatic diseases to explore self-protection strategies and health behaviour including adherence to disease-modifying antirheumatic treatment (DMARD) during the initial phase of the COVID-19 pandemic and again after the reopening of the society started. Furthermore, to identify characteristics of patients with high levels of anxiety and self-isolation.Methods Patients in routine care followed prospectively in the nationwide DANBIO registry were invited to answer an online questionnaire regarding disease activity and COVID-19 infection, behaviour in March and June 2020. Responses were linked to patient data in DANBIO. Characteristics potentially associated with anxiety, self-isolation and medication adherence (gender/age/diagnosis/education/work status/comorbidity/DMARD/smoking/EQ-5D/disease activity) were explored with multivariable logistic regression analyses.Results We included 12 789 patients (8168 rheumatoid arthritis/2068 psoriatic arthritis/1758 axial spondyloarthritis/795 other) of whom 65% were women and 36% treated with biological DMARD. Self-reported COVID-19 prevalence was 0.3%. Patients reported that they were worried to get COVID-19 infection (March/June: 70%/45%) and self-isolated more than others of the same age (48%/38%). The fraction of patients who changed medication due to fear of COVID-19 were 4.1%/0.6%. Female gender, comorbidities, not working, lower education, biological treatment and poor European Quality of life, 5 dimensions were associated with both anxiety and self-isolation.Conclusion In >12 000 patients with inflammatory arthritis, we found widespread anxiety and self-isolation, but high medication adherence, in the initial phase of the COVID-19 pandemic. This persisted during the gradual opening of society during the following months. Attention to patients’ anxiety and self-isolation is important during this and potential future epidemics. ER -